Galenica AG (SWX:GALE)

Market Cap	4.07B -4.8%
Revenue (ttm)	4.29B +6.4%
Net Income	159.18M -17.2%
EPS	3.19 -17.4%
Shares Out	49.82M
PE Ratio	25.28
Forward PE	20.16
Dividend	2.50 (3.06%)
Ex-Dividend Date	Apr 23, 2026

Volume	252,526
Open	82.60
Previous Close	82.90
Day's Range	81.60 - 83.15
52-Week Range	80.30 - 103.00
Beta	0.28
Analysts	Hold
Price Target	87.60 (+7.35%)
Earnings Date	Mar 9, 2027

About Galenica AG

Galenica AG provides healthcare services in Switzerland and internationally. It operates through two segments, Products & Care, and Logistics & IT. The Products & Care segment operates and manages pharmacies and partner pharmacies under the Amavita, Sun Store, and Coop Vitality brands, as well as covers specialty pharmacy mediservice. This segment also offers medication for treatment of patients at home; laboratory medicine, pathology and specialized personalized diagnostic services; and develops, markets, and sells healthcare services and prod...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1927
• Employees: 6,623
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: GALE

Financial Performance

In 2025, Galenica AG's revenue was 4.15 billion, an increase of 5.48% compared to the previous year's 3.93 billion. Earnings were 181.10 million, a decrease of -1.01%.

Analyst Summary

According to 5 analysts, the average rating for GALE stock is "Hold." The 12-month stock price target is CHF 87.60, which is an increase of 7.35% from the latest price.

Price Target

CHF 87.60

(7.35% upside)

Analyst Consensus: Hold

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 18, 2026

Data Sources Report a data error